Items tagged “prostate cancer”
7 results found
Article
Brachytherapy
Brachytherapy, also known as sealed source radiotherapy or endocurietherapy, is a form of radiotherapy where a radioactive source is placed, under the guidance of imaging, within or next to the area requiring treatment. This provides localized targeted internal radiation.
Brachytherapy has been...
Article
Prostate Imaging-Reporting and Data System (PI-RADS)
PI-RADS (Prostate Imaging–Reporting and Data System) is a structured reporting scheme for multiparametric prostate MRI in the evaluation of suspected prostate cancer in treatment naive prostate glands. This article reflects version 2.1 (v2.1), published in 2019 and developed by an internationall...
Article
SpaceOAR
SpaceOAR is a technique in which a physical space is created between the prostate gland and rectum for electron beam radiotherapy targeted to the prostate gland in cases of prostate cancer.
OAR stands for "organ at risk", and in cases of prostate cancer radiotherapy treatment the rectum is the...
Article
Prostate-specific membrane antigen
Prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II, is a type II transmembrane glycoprotein that has become an increasingly prominent imaging biomarker 1. PSMA has emerged as a useful target in PET imaging of prostate cancer, especially in the evaluation of sm...
Article
PSMA theranostics
PSMA theranostics is an emerging nuclear medicine approach in the management of prostate cancer that combines the use of prostate-specific membrane antigen (PSMA)-targeted imaging and therapy 1. PSMA-targeted imaging can be used to identify and locate prostate cancer cells, while PSMA radioligan...
Article
Lutetium-177 vipivotide tetraxetan
Lutetium-177 vipivotide tetraxetan, trade name Pluvicto, also known as 177Lu-PSMA-617, is a theranostic (i.e. both therapeutic and diagnostic) agent approved as a treatment for adult patients with treatment-resistant advanced metastatic prostate cancer. The treatment works by binding to cancer ...
Article
Radium-223 dichloride
Radium-223 dichloride, trade name Xofigo, is a radiopharmaceutical approved for the treatment of patients with symptomatic bone metastases and no visceral disease from prostate cancer resistant to anti androgen therapy. The molecule mimics calcium and forms a complex with hydroxyapatite at sites...
Unable to process the form. Check for errors and try again.